List of Contents

Monocyte Activation Test Market Size, Share, and Trends 2024 to 2034

The global monocyte activation test market size is calculated at USD 687.99 million in 2025 and is forecasted to reach around USD 2,602.21 million by 2034, accelerating at a CAGR of 15.93% from 2025 to 2034. The North America market size surpassed USD 219.58 million in 2024 and is expanding at a CAGR of 16.09% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : April 2025
  • Report Code : 5975
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Monocyte Activation Test Market 

5.1. COVID-19 Landscape: Monocyte Activation Test Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Monocyte Activation Test Market, By Product

8.1. Monocyte Activation Test Market Revenue and Volume Forecast, by Product

8.1.1. MAT Kits

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Reagents

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Granular

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Monocyte Activation Test Market, By Source

9.1. Monocyte Activation Test Market Revenue and Volume Forecast, by Source

9.1.1. PBMC Based

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Cell Line Based

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Monocyte Activation Test Market, By Application

10.1. Monocyte Activation Test Market Revenue and Volume Forecast, by Application

10.1.1. Drug Development

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Vaccine Development

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Medical Device Testing

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Others

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Monocyte Activation Test Market, By End Use

11.1. Monocyte Activation Test Market Revenue and Volume Forecast, by April

11.1.1. Pharmaceutical Industry

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Biotechnology Industry

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Medical Device Industry

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Others

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Monocyte Activation Test Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product

12.1.2. Market Revenue and Volume Forecast, by Source

12.1.3. Market Revenue and Volume Forecast, by Application

12.1.4. Market Revenue and Volume Forecast, by April

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product

12.1.5.2. Market Revenue and Volume Forecast, by Source

12.1.5.3. Market Revenue and Volume Forecast, by Application

12.1.5.4. Market Revenue and Volume Forecast, by April

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product

12.1.6.2. Market Revenue and Volume Forecast, by Source

12.1.6.3. Market Revenue and Volume Forecast, by Application

12.1.6.4. Market Revenue and Volume Forecast, by April

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product

12.2.2. Market Revenue and Volume Forecast, by Source

12.2.3. Market Revenue and Volume Forecast, by Application

12.2.4. Market Revenue and Volume Forecast, by April

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product

12.2.5.2. Market Revenue and Volume Forecast, by Source

12.2.5.3. Market Revenue and Volume Forecast, by Application

12.2.5.4. Market Revenue and Volume Forecast, by April

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product

12.2.6.2. Market Revenue and Volume Forecast, by Source

12.2.6.3. Market Revenue and Volume Forecast, by Application

12.2.6.4. Market Revenue and Volume Forecast, by April

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product

12.2.7.2. Market Revenue and Volume Forecast, by Source

12.2.7.3. Market Revenue and Volume Forecast, by Application

12.2.7.4. Market Revenue and Volume Forecast, by April

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product

12.2.8.2. Market Revenue and Volume Forecast, by Source

12.2.8.3. Market Revenue and Volume Forecast, by Application

12.2.8.4. Market Revenue and Volume Forecast, by April

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product

12.3.2. Market Revenue and Volume Forecast, by Source

12.3.3. Market Revenue and Volume Forecast, by Application

12.3.4. Market Revenue and Volume Forecast, by April

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product

12.3.5.2. Market Revenue and Volume Forecast, by Source

12.3.5.3. Market Revenue and Volume Forecast, by Application

12.3.5.4. Market Revenue and Volume Forecast, by April

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product

12.3.6.2. Market Revenue and Volume Forecast, by Source

12.3.6.3. Market Revenue and Volume Forecast, by Application

12.3.6.4. Market Revenue and Volume Forecast, by April

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product

12.3.7.2. Market Revenue and Volume Forecast, by Source

12.3.7.3. Market Revenue and Volume Forecast, by Application

12.3.7.4. Market Revenue and Volume Forecast, by April

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product

12.3.8.2. Market Revenue and Volume Forecast, by Source

12.3.8.3. Market Revenue and Volume Forecast, by Application

12.3.8.4. Market Revenue and Volume Forecast, by April

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product

12.4.2. Market Revenue and Volume Forecast, by Source

12.4.3. Market Revenue and Volume Forecast, by Application

12.4.4. Market Revenue and Volume Forecast, by April

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product

12.4.5.2. Market Revenue and Volume Forecast, by Source

12.4.5.3. Market Revenue and Volume Forecast, by Application

12.4.5.4. Market Revenue and Volume Forecast, by April

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product

12.4.6.2. Market Revenue and Volume Forecast, by Source

12.4.6.3. Market Revenue and Volume Forecast, by Application

12.4.6.4. Market Revenue and Volume Forecast, by April

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product

12.4.7.2. Market Revenue and Volume Forecast, by Source

12.4.7.3. Market Revenue and Volume Forecast, by Application

12.4.7.4. Market Revenue and Volume Forecast, by April

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product

12.4.8.2. Market Revenue and Volume Forecast, by Source

12.4.8.3. Market Revenue and Volume Forecast, by Application

12.4.8.4. Market Revenue and Volume Forecast, by April

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product

12.5.2. Market Revenue and Volume Forecast, by Source

12.5.3. Market Revenue and Volume Forecast, by Application

12.5.4. Market Revenue and Volume Forecast, by April

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product

12.5.5.2. Market Revenue and Volume Forecast, by Source

12.5.5.3. Market Revenue and Volume Forecast, by Application

12.5.5.4. Market Revenue and Volume Forecast, by April

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product

12.5.6.2. Market Revenue and Volume Forecast, by Source

12.5.6.3. Market Revenue and Volume Forecast, by Application

12.5.6.4. Market Revenue and Volume Forecast, by April

Chapter 13. Company Profiles

13.1. Lonza Group

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerProductance

13.1.4. Recent Initiatives

13.2. Abbott

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerProductance

13.2.4. Recent Initiatives

13.3. Charles River Laboratories

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerProductance

13.3.4. Recent Initiatives

13.4. Bio-Rad Laboratories

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerProductance

13.4.4. Recent Initiatives

13.5. Merck KGaA

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerProductance

13.5.4. Recent Initiatives

13.6. Abbott

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerProductance

13.6.4. Recent Initiatives

13.7. Seikagaku Corporation

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerProductance

13.7.4. Recent Initiatives

13.8. Hyglos GmbH

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerProductance

13.8.4. Recent Initiatives

13.9. Wako Chemicals U.S.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerProductance

13.9.4. Recent Initiatives

13.10. Thermo Fisher Scientific

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerProductance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global monocyte activation test market size is expected to grow from USD 593.45 million in 2024 to USD 2,602.21 million by 2034.

The monocyte activation test market is anticipated to grow at a CAGR of 15.93% between 2025 and 2034.

The major players operating in the monocyte activation test market are Lonza Group, Charles River Laboratories, Bio-Rad Laboratories, Merck KGaA, Seikagaku Corporation, Hyglos GmbH, Wako Chemicals U.S., Thermo Fisher Scientific, MAT BioTech, Eurofins Scientific, and Others

The driving factors of the monocyte activation test market are the growing awareness regarding ethical testing methods, innovations in monocyte activation test (MAT) technology.

North America region will lead the global monocyte activation test market during the forecast period 2025 to 2034.

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us